We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+1.46%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5.47B
AUM Growth
+$5.28M
Cap. Flow
+$84.4M
Cap. Flow %
1.54%
Top 10 Hldgs %
38.56%
Holding
3,811
New
262
Increased
1,518
Reduced
1,059
Closed
194
Avg Time Held Equity + Options
4.9 years
Top 10 Avg Time Held Equity + Options
3.2 years
Top 20 Avg Time Held Equity + Options
4.3 years
Avg Time Held Equity only
4.9 years
Top 10 Avg Time Held Equity only
3.2 years
Top 20 Avg Time Held Equity only
4.3 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.44%
2 Technology 18.26%
3 Financials 6.95%
4 Healthcare 6.81%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
WKHS icon
3576
Workhorse Group
WKHS
$31.7M
$5 ﹤0.01%
+1
New +$10
2025 Q2
2 quarters
GTIP icon
3577
Goldman Sachs Access Inflation Protected USD Bond ETF
GTIP
$290M
– –
0
– –
2025 Q4
0 quarters
LPL icon
3578
LG Display
LPL
$2.65B
$4 ﹤0.01%
1
– –
2021 Q2
18 quarters
CRON icon
3579
Cronos Group
CRON
$1.19B
$3 ﹤0.01%
1
– –
2022 Q1
15 quarters
BLMN icon
3580
Bloomin' Brands
BLMN
$847M
– –
-48
Closed -$334 –
CCO icon
3581
Clear Channel Outdoor Holdings
CCO
$1.23B
$2 ﹤0.01%
1
– –
2023 Q2
10 quarters
IMUX icon
3582
Immunic
IMUX
$95.2M
– –
0
– –
2018 Q2
30 quarters
KALA icon
3583
KALA BIO
KALA
$3.66M
– –
0
– –
2021 Q1
19 quarters
XXII
3584
22nd Century Group
XXII
$451K
– –
0
– –
2018 Q2
30 quarters
ACCO icon
3585
Acco Brands
ACCO
$419M
– –
-23
Closed -$92 –
ADAP
3586
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-250
Closed -$33 –
ADVM icon
3587
DELISTED
Adverum Biotechnologies
ADVM
– –
-50
Closed -$227 –
AGL icon
3588
Agilon Health
AGL
$1.47B
– –
-312
Closed -$8.04K –
AGM icon
3589
Federal Agricultural Mortgage
AGM
$2.23B
– –
-2
Closed -$336 –
AKRO icon
3590
DELISTED
Akero Therapeutics
AKRO
– –
-1,166
Closed -$55.4K –
ALE icon
3591
DELISTED
Allete
ALE
– –
-938
Closed -$62.3K –
AMN icon
3592
AMN Healthcare
AMN
$1.51B
– –
-13
Closed -$252 –
AOD icon
3593
abrdn Total Dynamic Dividend Fund
AOD
$1.07B
– –
-1,583
Closed -$15K –
AOUT icon
3594
American Outdoor Brands
AOUT
$220M
– –
-70
Closed -$608 –
APLT icon
3595
DELISTED
Applied Therapeutics
APLT
– –
-100
Closed -$60 –
ARTNA icon
3596
Artesian Resources
ARTNA
$344M
– –
-9
Closed -$293 –
AVDX icon
3597
DELISTED
AvidXchange
AVDX
– –
-141
Closed -$1.4K –
BAND icon
3598
Bandwidth Inc
BAND
$1.52B
– –
-46
Closed -$767 –
BCAT icon
3599
BlackRock Capital Allocation Term Trust
BCAT
$1.39B
– –
-3,200
Closed -$47.3K –
BIP icon
3600
Brookfield Infrastructure Partners
BIP
$17B
– –
-150
Closed -$4.93K –

Similar funds

Parallel Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, Parallel Advisors held 3,811 positions worth $5.47B, up 0.1% from $5.46B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Parallel Advisors's Q4 2025 filing shows 262 new, 1,518 increased, 1,059 reduced and 194 closed positions. Its largest new stake was iShares iBonds Dec 2032 Term Treasury ETF: 66,034 shares worth $1.52M. The largest sale was PIMCO Ultra Short Government Active ETF, an estimated $6.6M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 47% a quarter earlier, followed by Technology and Financials.

  • Parallel Advisors's largest Q4 2025 buy was iShares iBonds Dec 2032 Term Treasury ETF: 66,034 shares worth $1.52M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $11M increase.
  • Parallel Advisors's biggest Q4 2025 reduction was PIMCO Ultra Short Government Active ETF, cutting an estimated $6.6M.
  • Parallel Advisors fully exited iShares iBonds Dec 2025 Term Corporate ETF in Q4 2025, selling an estimated $5.01M.
  • Parallel Advisors's ten largest holdings make up 39% of its $5.47B portfolio in Q4 2025.
  • Parallel Advisors opened 262 new positions and closed 194 in Q4 2025.
  • Parallel Advisors's portfolio value rose 0.1% quarter-over-quarter to $5.47B.

Based on Parallel Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.